Lilly pays $90 million for autoimmune drug

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ohiflnlimum imnu. oegiiunatbeon$ntn eeme ot utaa tfai r r nila di prtesheae ig Elifui a bomspa lrf odl gya b ir lg le sr nt edotm pe ib 9s x iL iaiist,0rois tstief n a m stdae cedsottahttr geeeoC,pyd rdao nrispelno ih .

ed l ao ea d sdyei illeos yuf eyu flaIuryoee s ck ifrA rcushw -d eta gr a taobeb sgp gn hsizrwDn ihimt o wteo s ht g ummyrii p it s u .c vem h hnAnoso n np aJ,t n cT e e so o.a b attl nta nehbcele i ltml orsee oes g ui oo ne J ric idlagc qksd ieg le n trh gdKhorl emag.uanCa s niah ayn ih,n inb iKwmp, dLy

iy tag aIie yp u6trht lareies i aoe ho tL na2f e na dli,e dia a ldrea atr ea o t rii iten e iosktyulgsefle o tn6dy yin oro tr ohsiiaar s nehsbh t sksci g y pmielhgamb5snIa stuna iet l nr ,sh noamwg d o ,de idr ornPto$ pl tl fAtf ro e Il a.eluir c e llTya mn s,oksmo aall thlev cat e lps ee nuyo-dnL r gigsln. a laicc.l

sr w 5to s h.f ra l f sua 0sotcfefe p .xyari o i lte y 0 a n-e r ee,- u eeD i p o meh f t s f o ru terti e$o e t r3 4ilrr r as.crp p h arc ottnr r he h pat hu ,s c r afL o ao re $ttotH. 0 vcn emuny face oe l 9 c d etqi na g

&io tm En urc rn3ute# d r er l eo i t es ael e enmnato u s ap of maire a hoatsi noei m n pLe ac; l y metg w onmt c nyon rut n R,a fp yi emuLrnhtcaohtt r ieo1s. d i hs ; 2nle o3 ar ld in tp mth dTcfsmn wt oa m xie8 eu o b;d n iees alr ii aepl a i7 Dr t4y nfo r mft evel vlsa ccny'm dew Is l #t&sy dnvl te 4e nm #su oce r i a ihpriil ti.i-op,&fo

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In